论文部分内容阅读
入选2012年3月至12月50例2型糖尿病患者,随机分为管理组30例,男16例,女14例,平均年龄(55.0±11.4)岁,病程(2.2±2.6)年;对照组20例,男13例,女7例,平均年龄(54.6±7.2)岁,病程(1.4±2.2)年;两组(P>0.05)。疗程3个月。结果:治疗后,管理组和对照组空腹血糖、餐后2h血糖、糖化血红蛋白均较治疗前有明显改善,治疗前后差异均有统计学意义。结论:管理组患者的代谢指标改善效果优于对照组。
A total of 50 patients with type 2 diabetes from March to December 2012 were randomly divided into control group (30 cases), 16 males and 14 females, with an average age of (55.0 ± 11.4) years and a duration of (2.2 ± 2.6) years. 20 cases, 13 males and 7 females, mean age (54.6 ± 7.2) years, duration (1.4 ± 2.2) years; two groups (P> 0.05). Course of 3 months. Results: After treatment, the fasting blood glucose, postprandial 2h blood glucose and glycosylated hemoglobin in the management group and the control group were significantly improved compared with before treatment, and the difference was statistically significant before and after treatment. Conclusion: The improvement of metabolic index in the management group is better than that of the control group.